BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lessened its stake in shares of CME Group Inc (NASDAQ:CME) by 20.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 196,304 shares of the financial services provider’s stock after selling 50,349 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp owned about 0.06% of CME Group worth $26,635,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of CME. Fiduciary Trust Co. bought a new position in CME Group in the second quarter worth approximately $105,000. Quadrant Capital Group LLC raised its stake in CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA bought a new position in CME Group in the second quarter worth approximately $129,000. People s United Financial Inc. raised its stake in CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares in the last quarter. Finally, Mckinley Capital Management LLC Delaware bought a new position in CME Group in the second quarter worth approximately $150,000. 83.17% of the stock is owned by hedge funds and other institutional investors.
In other CME Group news, COO Julie Holzrichter sold 12,920 shares of the company’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total value of $1,861,513.60. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Dennis Suskind sold 750 shares of the company’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $129.34, for a total transaction of $97,005.00. Following the completion of the sale, the director now directly owns 5,059 shares in the company, valued at $654,331.06. The disclosure for this sale can be found here. Insiders have sold 34,921 shares of company stock worth $5,016,248 over the last three months. Corporate insiders own 0.57% of the company’s stock.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.05 earnings per share. analysts predict that CME Group Inc will post 4.78 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date is Thursday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 59.86%.
A number of equities analysts recently commented on CME shares. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Barclays upped their price target on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 10th. UBS reaffirmed a “buy” rating and set a $135.00 price target (up from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Royal Bank Of Canada upped their price target on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 price target on shares of CME Group in a research report on Friday, August 18th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $141.75.
COPYRIGHT VIOLATION WARNING: “CME Group Inc (CME) Shares Sold by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://www.chaffeybreeze.com/2017/12/06/cme-group-inc-cme-shares-sold-by-british-columbia-investment-management-corp.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.